# ShenFu Injection for Myocardial Protection in Patients With Acute ST Segment Elevation Myocardial Infarction

> **NCT02709798** · PHASE4 · COMPLETED · sponsor: **Beijing Anzhen Hospital** · enrollment: 40 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Shenfu Injection
- **DRUG:** 5% Glucose Injection

## Key facts

- **NCT ID:** NCT02709798
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2018-02
- **Final completion:** 2018-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02709798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02709798, "ShenFu Injection for Myocardial Protection in Patients With Acute ST Segment Elevation Myocardial Infarction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02709798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*